- Report
- October 2024
- 192 Pages
From €3262EUR$3,545USD£2,731GBP
€3624EUR$3,939USD£3,034GBP
- Report
- May 2025
- 193 Pages
Global
From €3262EUR$3,545USD£2,731GBP
€3624EUR$3,939USD£3,034GBP
- Report
- May 2025
- 186 Pages
Global
From €3262EUR$3,545USD£2,731GBP
€3624EUR$3,939USD£3,034GBP
- Report
- May 2025
- 194 Pages
Global
From €3262EUR$3,545USD£2,731GBP
€3624EUR$3,939USD£3,034GBP
- Report
- May 2025
- 189 Pages
Global
From €3262EUR$3,545USD£2,731GBP
€3624EUR$3,939USD£3,034GBP
- Report
- May 2025
- 187 Pages
Global
From €3262EUR$3,545USD£2,731GBP
€3624EUR$3,939USD£3,034GBP
- Report
- May 2025
- 190 Pages
Global
From €3262EUR$3,545USD£2,731GBP
€3624EUR$3,939USD£3,034GBP
- Report
- May 2025
- 191 Pages
Global
From €3262EUR$3,545USD£2,731GBP
€3624EUR$3,939USD£3,034GBP
- Report
- May 2025
- 183 Pages
Global
From €3262EUR$3,545USD£2,731GBP
€3624EUR$3,939USD£3,034GBP
- Report
- May 2025
- 181 Pages
Global
From €3262EUR$3,545USD£2,731GBP
€3624EUR$3,939USD£3,034GBP
- Report
- May 2025
- 184 Pages
Global
From €3262EUR$3,545USD£2,731GBP
€3624EUR$3,939USD£3,034GBP
- Report
- May 2025
- 192 Pages
Global
From €3262EUR$3,545USD£2,731GBP
€3624EUR$3,939USD£3,034GBP
- Report
- May 2025
- 196 Pages
Global
From €3262EUR$3,545USD£2,731GBP
€3624EUR$3,939USD£3,034GBP
- Report
- May 2025
- 190 Pages
Global
From €3262EUR$3,545USD£2,731GBP
€3624EUR$3,939USD£3,034GBP
- Report
- May 2025
- 180 Pages
Global
From €3262EUR$3,545USD£2,731GBP
€3624EUR$3,939USD£3,034GBP
- Report
- May 2025
- 198 Pages
Global
From €3262EUR$3,545USD£2,731GBP
€3624EUR$3,939USD£3,034GBP
- Report
- May 2025
- 180 Pages
Global
From €3262EUR$3,545USD£2,731GBP
€3624EUR$3,939USD£3,034GBP
- Report
- May 2025
- 198 Pages
Global
From €3262EUR$3,545USD£2,731GBP
€3624EUR$3,939USD£3,034GBP
- Report
- May 2025
- 190 Pages
Global
From €3262EUR$3,545USD£2,731GBP
€3624EUR$3,939USD£3,034GBP
- Report
- May 2025
- 195 Pages
Global
From €3262EUR$3,545USD£2,731GBP
€3624EUR$3,939USD£3,034GBP

The Inhalers and Nebulisers market is a segment of the medical device industry that focuses on the development and production of devices used to deliver medication to the lungs. Inhalers and nebulisers are used to treat a variety of respiratory conditions, including asthma, COPD, and cystic fibrosis. Inhalers are handheld devices that deliver medication directly to the lungs in the form of a mist or aerosol. Nebulisers are larger devices that use a compressor to convert liquid medication into a mist that can be inhaled.
Inhalers and nebulisers are used by millions of people around the world, and the market is expected to grow in the coming years. Companies in the market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, and Teva Pharmaceuticals. These companies are involved in the development and production of inhalers and nebulisers, as well as the research and development of new treatments for respiratory conditions. Show Less Read more